Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Sangro

Showing results (121-130 of 329) with videos related to

Pageof 33
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 30, 2011
Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawalJ Ignacio Herrero, Fernando Pardo, Delia D'Avola, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2003
Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancyJ Ignacio Herrero, Juan Felipe Lucena, Jorge Quiroga, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2018
Segmental Pneumonitis after RadioembolizationJosé I Bilbao Jaureguizar, Lidia Sancho, María Páramo, et al.
BJS Open|April 28, 2023
Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertensionDaniel Aliseda, Gabriel Zozaya, Pablo Martí-Cruchaga, et al.
Annals of Transplantation|March 18, 2017
Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver TransplantationDiego Aguiar, Diego Martínez-Urbistondo, Delia D'Avola, et al.
Gastroenterology|December 31, 2003
Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancerLin Wang, Rubén Hernández-Alcoceba, Vijay Shankar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 21, 2011
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantationCarlos Gomez-Martin, Javier Bustamante, Javier F Castroagudin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 21, 2019
Medical treatment for cholangiocarcinomaJorge Adeva, Bruno Sangro, Maximiliano Salati, et al.
Functional & Integrative Genomics|May 13, 2011
A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinomaPaul C Schröder, Víctor Segura, José Ignacio Riezu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2021
Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and GrowthMarina Barriocanal, Celia Prior, Beatriz Suarez, et al.
Pageof 33

Showing results (121-130 of 329) with videos related to

Sort By:
Pageof 33
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 30, 2011
Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawalJ Ignacio Herrero, Fernando Pardo, Delia D'Avola, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 4, 2003
Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancyJ Ignacio Herrero, Juan Felipe Lucena, Jorge Quiroga, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 28, 2018
Segmental Pneumonitis after RadioembolizationJosé I Bilbao Jaureguizar, Lidia Sancho, María Páramo, et al.
BJS Open|April 28, 2023
Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertensionDaniel Aliseda, Gabriel Zozaya, Pablo Martí-Cruchaga, et al.
Annals of Transplantation|March 18, 2017
Conversion from Calcineurin Inhibitor-Based Immunosuppression to Mycophenolate Mofetil in Monotherapy Reduces Risk of De Novo Malignancies After Liver TransplantationDiego Aguiar, Diego Martínez-Urbistondo, Delia D'Avola, et al.
Gastroenterology|December 31, 2003
Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancerLin Wang, Rubén Hernández-Alcoceba, Vijay Shankar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 21, 2011
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantationCarlos Gomez-Martin, Javier Bustamante, Javier F Castroagudin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 21, 2019
Medical treatment for cholangiocarcinomaJorge Adeva, Bruno Sangro, Maximiliano Salati, et al.
Functional & Integrative Genomics|May 13, 2011
A signature of six genes highlights defects on cell growth and specific metabolic pathways in murine and human hepatocellular carcinomaPaul C Schröder, Víctor Segura, José Ignacio Riezu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 2021
Long Noncoding RNA EGOT Responds to Stress Signals to Regulate Cell Inflammation and GrowthMarina Barriocanal, Celia Prior, Beatriz Suarez, et al.
Pageof 33